GWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophrenia.
X Chen, G Lee, B S Maher...
https://pubmed.ncbi.nlm.nih.gov/20838396/Actively Recruiting
Led by University of Aberdeen · Updated on 2026-09-09
800
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are investigating Takotsubo cardiomyopathy, also known as acute stress-induced cardiomyopathy, which mimics a heart attack but occurs without blocked coronary arteries. This condition, triggered by intense emotional or physical stress, may carry a similar risk of death as a heart attack. The study aims to identify all cases of Takotsubo cardiomyopathy in Scotland since 2010 and analyze its epidemiology and outcomes. This observational study uses data collected centrally by Public Health Scotland, identifying patients coded for cardiomyopathies and ill-defined heart diseases. Confirmed Takotsubo cases will be registered and compared retrospectively and prospectively to two matched control groups a random sample from the Scottish population and patients with myocardial infarction. Data linkage will be used to assess outcomes, prescribing, and predictive scores. Participants include all patients diagnosed with Takotsubo cardiomyopathy since 2010. Researchers will collect clinical information and compare it with control groups to study mortality and morbidity over 13 years. The study will monitor specific causes of death and disease impact using electronic records, with outcomes tracked until the end of 2028.
CONDITIONS
Establishing the Incidence of Tako-tsubo Cardiomyopathy in Scotland
D
Dana Dawson, MD, MRCP
A
Amelia Rudd, HND
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Aberdeen
Lead Sponsor
NHS Tayside
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
X Chen, G Lee, B S Maher...
https://pubmed.ncbi.nlm.nih.gov/20838396/Matthew R Summers, Ryan J Lennon, Abhiram Prasad
https://pubmed.ncbi.nlm.nih.gov/20170799/David G Ashbrook, Robert W Williams, Lu Lu...
https://pubmed.ncbi.nlm.nih.gov/26190982/Abhiram Prasad, Amir Lerman, Charanjit S Rihal
https://pubmed.ncbi.nlm.nih.gov/18294473/M Madhavan, B A Borlaug, A Lerman...
https://pubmed.ncbi.nlm.nih.gov/19468013/Ilan S Wittstein, David R Thiemann, Joao A C Lima...
https://pubmed.ncbi.nlm.nih.gov/15703419/Dana K Dawson, Christopher J Neil, Anke Henning...
https://pubmed.ncbi.nlm.nih.gov/25499134/Fridolin Sy, Jagroop Basraon, Hong Zheng...
https://pubmed.ncbi.nlm.nih.gov/23683950/Ahmad A Elesber, Abhiram Prasad, Ryan J Lennon...
https://pubmed.ncbi.nlm.nih.gov/17662398/Christopher Neil, Thanh Ha Nguyen, Angela Kucia...
https://pubmed.ncbi.nlm.nih.gov/22791656/University of Aberdeen
Lead Sponsor
NHS Tayside
Collaborating Sponsor